Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lupin gets USFDA nod for hypertension treatment drug in US
Tuesday, December 27, 2016Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets used for treating high blood pressure in the American market It has received tentative rpt tentative approval for Olmesartan medoximil...
KYORIN Holdings to transfer unit to Taisho Pharmaceutical
Monday, December 26, 2016KYORIN Holdings Inc Says it to transfer its Japanbased unit DrProgram to Taisho Pharmaceutical Co Ltd that is a unit of Taisho Pharmaceutical Holdings Co Ltd Transaction price is not disclosed Says the transaction planned effective on April
Kubota Pharmaceutical Holdings Signs Letter of Intent to Form a Joint Venture with SBI Holdings
Monday, December 26, 2016Kubota Pharmaceutical Holdings Co Ltd a clinicalstage ophthalmology company committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide and SBI Holdings Inc SBI a f...
Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc
Saturday, December 24, 2016Taro Pharmaceutical Industries Ltd announced the sale of US rights to Keveyis dichlorphenamide to Strongbridge Biopharma plc Strongbridge a global commercialstage biopharmaceutical company focused on the development and commercialization of therapies...
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Saturday, December 24, 2016Pfizer Inc announced that it has completed the acquisition of the development and commercialization rights to AstraZenecas latestage small molecule antiinfective business primarily outside the United States The agreement includes the commercializatio...
PharmaMar and Chugai Pharmaceutical Enter into a License and Commercialization Agreement
Friday, December 23, 2016PharmaMar has announced today the signing of an exclusive license development and commercialization agreement with Chugai Pharmaceutical Co Ltd TSE for its third marinederived anticancer drug PM lurbinectedin in Japan Under the terms of this agreeme...
Roche’s emicizumab for haemophilia A meets primary endpoint in phase III study
Friday, December 23, 2016Roche announced that the primary endpoint has been met for the phase III HAVEN study evaluating emicizumab prophylaxis in people years of age or older with haemophilia A and inhibitors to factor VIII The study showed a statistically significant red...
Dipexium Pharmaceuticals and PLx Pharma Announce Merger Agreement
Friday, December 23, 2016Dipexium Pharmaceuticals Inc and PLx Pharma Inc a privately held latestage specialty pharmaceutical company announced today that they have entered into a definitive agreement under which PLx Pharma will merge with a whollyowned subsidiary of Dipexium...
Novartis out-licenses three COPD products in the US
Thursday, December 22, 2016Novartis announced that it has signed a licensing agreement with Sunovion Pharmaceuticals Inc Sunovion for the US commercial rights to its three treatments for chronic obstructive pulmonary disease COPD Utibron Neohaler indacaterolglycopyrrolate inha...
Concert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-656
Thursday, December 22, 2016Concert Pharmaceuticals Inc announced the initiation of a USbased Phase clinical trial evaluating CTP deuterated ivacaftor a next generation CFTR potentiator being developed for the treatment of cystic fibrosis CTP was created based on Concerts appl...
